BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21931131)

  • 1. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).
    Kielczewski JL; Li Calzi S; Shaw LC; Cai J; Qi X; Ruan Q; Wu L; Liu L; Hu P; Chan-Ling T; Mames RN; Firth S; Baxter RC; Turowski P; Busik JV; Boulton ME; Grant MB
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8278-86. PubMed ID: 21931131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3.
    Jarajapu YP; Cai J; Yan Y; Li Calzi S; Kielczewski JL; Hu P; Shaw LC; Firth SM; Chan-Ling T; Boulton ME; Baxter RC; Grant MB
    PLoS One; 2012; 7(7):e39398. PubMed ID: 22792172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
    Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
    Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
    Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
    J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
    Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
    Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Acting FGF21 Inhibits Retinal Vascular Leakage in In Vivo and In Vitro Models.
    Tomita Y; Fu Z; Wang Z; Cakir B; Cho SS; Britton W; Sun Y; Hellström A; Talukdar S; Smith LEH
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ.
    Suarez S; McCollum GW; Bretz CA; Yang R; Capozzi ME; Penn JS
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8232-40. PubMed ID: 25406289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEDF regulates vascular permeability by a γ-secretase-mediated pathway.
    Cai J; Wu L; Qi X; Li Calzi S; Caballero S; Shaw L; Ruan Q; Grant MB; Boulton ME
    PLoS One; 2011; 6(6):e21164. PubMed ID: 21695048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes.
    Wisniewska-Kruk J; Hoeben KA; Vogels IM; Gaillard PJ; Van Noorden CJ; Schlingemann RO; Klaassen I
    Exp Eye Res; 2012 Mar; 96(1):181-90. PubMed ID: 22200486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
    Kim SR; Suh W
    Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
    Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
    Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.
    Wisniewska-Kruk J; van der Wijk AE; van Veen HA; Gorgels TG; Vogels IM; Versteeg D; Van Noorden CJ; Schlingemann RO; Klaassen I
    Am J Pathol; 2016 Apr; 186(4):1044-54. PubMed ID: 26878208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
    Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
    Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
    Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGFBP-3 reduces eNOS and PKCzeta phosphorylation, leading to lowered VEGF levels.
    Zhang Q; Jiang Y; Steinle JJ
    Mol Vis; 2015; 21():604-11. PubMed ID: 26015772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
    Deissler HL; Deissler H; Lang GK; Lang GE
    Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells.
    Deissler HL; Deissler H; Lang GE
    Br J Ophthalmol; 2011 Aug; 95(8):1151-6. PubMed ID: 21273213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide reduces vascular leakage and choroidal neovascularization.
    Lara-Castillo N; Zandi S; Nakao S; Ito Y; Noda K; She H; Ahmed M; Frimmel S; Ablonczy Z; Hafezi-Moghadam A
    Am J Pathol; 2009 Dec; 175(6):2343-50. PubMed ID: 19910509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.